In the developed countries with a much higher percentage of postmenopausal breast cancer and a higher proportion of obese women, LEPR Gln223Arg polymorphism may be expected to have more impact on risk of the disease compared to the Nigerian population with a lower prevalence of obesity. This evidence concerns the gene LEPR and obesity due to melanocortin 4 receptor deficiency.